NCT01673659
A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)
Phase: Phase 3
Role: Lead Sponsor
Start: Aug 31, 2012
Completion: Oct 31, 2012